Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

BasinStBlues re:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
maverick_1 Member Profile
 
Followed By 59
Posts 2,834
Boards Moderated 0
Alias Born 06/28/14
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:22:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 5:05:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/18/2019 6:02:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/17/2019 5:24:27 PM
Biotech Companies with Recent and Potential Near-Term Catalysts InvestorsHub NewsWire - 7/15/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 12:11:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:24:36 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/2/2019 5:23:33 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/19/2019 5:19:39 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:33:33 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:20:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2019 5:26:54 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 1/8/2019 6:04:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/20/2018 4:18:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 4:17:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/28/2018 5:28:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2018 1:44:13 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2018 5:38:07 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/15/2018 3:15:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 4:49:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2018 4:24:26 PM
maverick_1   Wednesday, 08/14/19 12:39:04 PM
Re: Basin Street Blues post# 239685
Post # of 240608 
BasinStBlues re:
Quote:

So as NVCR hits new highs I guess the positive for NWBO is the institutional appetite for their shares.

An observation that few here are loathe to come to grips with given the clear hundred plus posts on Novocure’s Optune over just the last two months!

Has it ever dawn on those multitude of posters WHY their mindset is
NOT synchronized with that of the true marketplace?

BTW: Thanks to Truthfan posting of NVCR’s CEO interviewed by James Cramer
a few nights ago; my Baron’s posted interview with T Rowe Prices HC Fund Mgr;
recent CC: ALL that I’m aware of.

Covering the waterfront vs what’s been amply displayed!
Just like you asking 5 years ago: Why Institutional ownership
in NWBO so low should ring a bell

SAME can be said about NWBO!


Has anyone done any cost of treatments analysis, Optune vs DCVAX-L?

[Suppressed Image]

Replies:
Optune helmet: $20k/month Dcvax-l: probably $150k - $200k
sukus on 8/14/2019 8:50:57 AM

Optune is about USD20K per month, DCVax will
HKBobby on 8/14/2019 9:12:31 AM

So as NVCR hits new highs I guess the positive for NWBO is the institutional appetite for their shares.

Has anyone done any cost of treatments analysis, Optune vs DCVAX-L?

[Suppressed Image]




Replies:
Optune helmet: $20k/month Dcvax-l: probably $150k - $200k
sukus on 8/14/2019 8:50:57 AM
Optune is about USD20K per month, DCVax will
HKBobby on 8/14/2019 9:12:31 AM
Re: Basin Street Blues Post# 239685
Optune is about USD20K per month, DCVax will be less, probably between USD12-15k per month. And unlike Optune DCVax actually works.
Replies:
And, you can leave your microwave oven at
Hansm7777 on 8/14/2019 9:25:21



Re: sukus Post# 239717
Sukus re:
Quote:
Optune helmet: $20k/month
Dcvax-l: probably $150k - $200k


INCOMPLETE analysis! and just those comments above in last hour??

The critical analysis will demonstrate:
Over 3 years IF anyone could afford NVCR’s Optune
BEFORE any Insurance Reimbursements ie Medicare etc Is $720,000. Don't know if NVCR has ever commented on average patients length of use!

One time DCVAX L lasts 3 yrs for ~$150,000 plus?

So for the money NO CONTEST

For ALL the years NVCR Optune has been approved
for nGBM not a large ongoing customer base ( likely due to No Medicare CMS Reimbursement until this past June 2019!

Apparently everyone here just Pisses over NVCR:
AND it is clearly apparent NO ONE has parsed even
ONE of their CORPORATE PRESENTATIONS let alone a conference call. CLOSED mindsets! Yet another addition to the long procession of INCOMPLETE
Due Diligence on top of absence of preservation of capital via minimizing the runaway losses here!

STARK CONTRAST

On top of:
O/S Optune only 3-4 mos above SOC
O/S DCVAX L ~25 mos above SOC

ReOccurence stats for each?

Not to mention the daily 18 hr inconvenience
of head gear/ backpack

So clearly DISRUPTIVE DC technology platform
most especially with the promise of DIRECT’s impact!

That’s why

DIFFERENCE STROKES FOR DIFFERENT FOLKS
Replies:
Thanks Mav! Excellent!
sukus on 8/14/2019 12:16:01 PM























DIFFERENT STROKES FOR DIFFERENT FOLKS
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist